NCE (new chemical entities) is strictly protected by patents and has substantial economic benefits. At present, major pharmaceutical companies in the world are committed to the research and development of NCE. De novo drug design technology is one of the CADD technologies applicable to NCE research and development. It is a drug molecule design method based on the three-dimensional structure of the receptor. This technology analyzes the target molecule's active site and constructs a drug molecule that matches the active site.
|Analyze the active site of the target to determine the distribution of active sites, potential fields and key functional residues.|
|Use different strategies to put the basic building blocks into the active site and generate completed new molecules.|
|Calculate the binding energy of new molecules and receptor molecules to predict biological activity.|
|Project name||De novo Design|
|Samples requriements||Our drug design service requires you to provide specific drug screening requirements.|
|Detection cycle||Decide according to your needs.|
|Service including||We provide you with raw data and calculation result analysis service.|
The advantage of the de novo design technology is to provide new ideas for the development of new drugs, make full use of the structural information of known compounds, and to a certain extent avoid the waste of research and development resources and accelerate the speed of new drug development. It has strong feasibility and broad development prospects, and may become an important tool for new drug research and development.
ComputaBio is a professional and efficient team. The team has more than 40% of employees with master degree, doctor degree and above. Treating customers' projects ComputaBio is racing against time, mission must be reached, efficient and timely delivery of tasks, customer satisfaction and trust. If you have drug design needs, please feel free to contact us.